Literature DB >> 12401958

Brain iron metabolism and neurodegenerative disorders.

Jack C Sipe1, Pauline Lee, Ernest Beutler.   

Abstract

Iron, an essential element for central nervous system (CNS) function, has frequently been found to accumulate in brain regions that undergo degeneration in neurological diseases such as Alzheimer disease, Parkinson disease, Friedreich ataxia and other disorders. However, the precise role of iron in the cause of many neurodegenerative diseases is unclear. To assist in understanding the potential importance of iron in CNS disease, this review summarizes the present knowledge in the areas of CNS iron metabolism, homeostasis and disregulation of iron balance caused by mutations in genes encoding proteins involved in iron transport, storage and metabolism. This review encompasses neurodegenerative disorders associated with both iron overload and deficiency to highlight areas where iron misregulation is likely to be important in the pathophysiology of several human brain diseases. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401958     DOI: 10.1159/000065701

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  24 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

Review 2.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 3.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

4.  Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study.

Authors:  E Raz; J H Jensen; Y Ge; J S Babb; L Miles; J Reaume; R I Grossman; M Inglese
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

5.  Iron increases APP translation and amyloid-beta production in the retina.

Authors:  Lucie Y Guo; Oleg Alekseev; Yafeng Li; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2014-10-16       Impact factor: 3.467

6.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

7.  Association of neurobehavioral performance with R2* in the caudate nucleus of asymptomatic welders.

Authors:  Eun-Young Lee; Paul J Eslinger; Michael R Flynn; Daymond Wagner; Guangwei Du; Mechelle M Lewis; Lan Kong; Richard B Mailman; Xuemei Huang
Journal:  Neurotoxicology       Date:  2016-11-18       Impact factor: 4.294

8.  Phase contrast imaging in neonates.

Authors:  Kai Zhong; Thomas Ernst; Steve Buchthal; Oliver Speck; Lynn Anderson; Linda Chang
Journal:  Neuroimage       Date:  2011-01-11       Impact factor: 6.556

9.  Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates.

Authors:  Tatyana Verina; Samara F Kiihl; Jay S Schneider; Tomás R Guilarte
Journal:  Neurotoxicology       Date:  2010-11-26       Impact factor: 4.294

10.  Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

Authors:  Wei Zhang; Sheng-Gan Sun; Yu-Hong Jiang; Xian Qiao; Xin Sun; Yan Wu
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.